You are in: eMedicine Specialties > Vascular Surgery > MEDICAL TOPICS Abdominal Aortic AneurysmArticle Last Updated: Dec 17, 2007AUTHOR AND EDITOR INFORMATIONSection 1 of 12
  Author: William H Pearce, MD, Chief, Division of Vascular Surgery, Violet and Charles Baldwin Professor of Vascular Surgery, Department of Surgery, Northwestern University School of Medicine William H Pearce is a member of the following medical societies: American College of Surgeons, American Heart Association, American Surgical Association, Association for Academic Surgery, Association of VA Surgeons, Central Surgical Association, New York Academy of Sciences, Society for Vascular Surgery, Society of Critical Care Medicine, Society of University Surgeons, and Western Surgical Association Coauthor(s): Brian G Peterson, MD, Fellow in Vascular Surgery, McGaw-Northwestern University Editors: Jeffrey Lawrence Kaufman, MD, Associate Professor, Department of Surgery, Division of Vascular Surgery, Tufts University School of Medicine; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Travis J Phifer, MD, Chief, Division of Vascular Surgery, Professor, Department of Surgery and Radiology, Louisiana State University Health Sciences Center in Shreveport; Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy; John Geibel, MD, DSc, MA, Professor, Department of Surgery, Section of Gastrointestinal Medicine and Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director of Surgical Research, Department of Surgery, Yale-New Haven Hospital Author and Editor Disclosure Synonyms and related keywords: abdominal aortic aneurysm, aortic ectasia, arteriomegaly, diffuse arterial enlargement, atherosclerotic vascular disease, Marfan's syndrome, Marfan syndrome, AAA, aortic rupture, atherosclerosis, Dacron, Gore-Tex INTRODUCTIONSection 2 of 12
  Abdominal aortic aneurysms (AAAs) represent a degenerative process of the abdominal aorta that is often attributed to atherosclerosis; however, the exact cause is not known. A familiar clustering of AAAs has been noted in 15-25% of patients undergoing repair of the problem. Degenerative aneurysms account for more than 90% of all infrarenal AAAs. Other causes include infection, cystic medial necrosis, arteritis, trauma, inherited connective-tissue disorders, and anastomotic disruption. The disease generally affects elderly white men. Smoking appears to be the risk factor most strongly associated with AAA. History of the ProcedureVesalius described the first AAA in the 16th century. Before the development of a surgical intervention for the process, attempts at medical management failed. The initial attempts at control used ligation of the aorta, with the expected consequences. In 1923, Matas performed the first successful aortic ligation on a patient. Attempts were made to induce thrombosis by inserting intraluminal wires. In 1948, Rea wrapped reactive cellophane around the aneurysm in order to induce fibrosis and limit expansion. This technique was used on Albert Einstein in 1949, and he survived 6 years before succumbing to rupture. In 1951, Charles Dubost performed the first AAA repair using a homograft. Prior to this, aortic aneurysms were treated using a variety of methods, including ligation, intraluminal wiring, and cellophane wrapping. Unfortunately, early homografts became aneurysmal because of preservation techniques. In 1953, Blakemore and Voorhees repaired a ruptured AAA using a Vinyon-N graft (ie, nylon). Later, these grafts were replaced by Dacron and Gore-Tex (ie, polytetrafluoroethylene [PTFE]) fabrics. The final advance was abandonment of silk sutures, which degenerated, in favor of braided Dacron, polyethylene, and PTFE (ie, Gore-Tex) sutures, all of which retain tensile strength. Postoperative surgical mortality rates initially remained high (>25%) because the aneurysm sac generally was excised. Nearly simultaneously in 1962, Javid and Creech reported the technique of endoaneurysmorrhaphy (see Image 1). This advancement dramatically reduced mortality. Today, operative mortality rates range from 1.8-5%. In the late 1980s, Parodi et al described endovascular repair using a large Palmaz stent and unilateral aortofemoral and femorofemoral crossover Dacron grafts.1 Currently, many devices are used for the endovascular treatment of AAA (see Image 2). ProblemAneurysms are defined as a focal dilatation with at least a 50% increase over normal arterial diameter. Thus, an enlargement of at least 3 cm of the abdominal aorta fits the definition. In large ultrasound screening studies, increasing age; male sex; African American race; and increased height, weight, body mass index, and body surface area all were associated with increased infrarenal aortic diameter. Most cases of AAA begin below the renal arteries and end above the iliac arteries. They generally are spindle shaped; however, size, shape, and extent vary considerably. Of AAA cases, 10-20% have focal outpouchings or blebs that are thought to contribute to the potential for rupture. The wall of the aneurysm becomes laminated with thrombus as the blebs enlarge. This can give the appearance of a relatively normal intraluminal diameter in spite of a large extraluminal size. FrequencyAAAs are uncommon in African Americans, Asians, and persons of Hispanic heritage. United States In autopsy studies, the frequency rate of AAA ranges from 0.5-3.2%. In a large US Veterans Administration screening study, the prevalence rate was 1.4%.2 The frequency of rupture is 4.4 cases per 100,000 persons. AAA is 5 times more common in men than in women and is 3.5 times more common in white males than in African American males. The likelihood of development varies from 3-117 cases per 100,000 person-years. In men, the process appears to begin at approximately age 50 years and reaches peak incidence at approximately age 80 years. In women, the onset is delayed and appears to begin at approximately age 60 years. The reported incidence of rupture varies from 1-21 cases per 100,000 person-years. International The frequency rate of asymptomatic AAA is 8.2% in the United Kingdom, 8.8% in Italy, 4.2% in Denmark, and 8.5% in Sweden (in males only). The frequency rate of AAA in females is much lower, 0.6-1.4%. The frequency of rupture is 6.9 cases per 100,000 persons in Sweden, 4.8 cases per 100,000 persons in Finland, and 13 cases per 100,000 persons in the United Kingdom. Risk factors The peak incidence of AAA occurs in people aged 70 years (see Image 3). The male-to-female incidence ratio in people younger than 80 years is 2:1. When older than 80 years, the ratio changes to 1:1. A family history of AAA is a risk factor for AAA. Approximately 25% of cases are in persons with first-degree relatives with AAA. Other risk factors include previous aneurysm repair or peripheral aneurysm (popliteal or femoral), smoking, coronary artery disease, and hypertension (1-15%). EtiologyAAA is thought to be a degenerative process of the aorta, the cause of which remains unclear. It is often attributed to atherosclerosis because these changes are observed in the aneurysm at the time of surgery. Atherosclerosis fails to explain the development of occlusion, which is observed in the disease process. AAA appears to have a familial prevalence rate of 15-25%. Studies by Majumder and associates suggest the genetic predisposition is isolated to a single dominant gene with low penetrance that increases with age.3 Tilson et al described the potential for an autoimmune basis for the development of AAA involving the DRB1 major histocompatibility locus.4 This locus has been identified as a basis for inflammatory AAA. The other causes of AAA include infection, cystic medial necrosis, arteritis, trauma, inherited connective-tissue (structural collagen) disorders, and anastomotic disruption producing pseudoaneurysms. PathophysiologyA multidisciplinary research program supported by the US National Heart, Lung, and Blood Institute identified proteolytic degradation of aortic wall connective tissue, inflammation and immune responses, biomechanical wall stress, and molecular genetics as mechanisms important in the development of AAA.5 The aortic wall contains smooth muscle, elastin, and collagen arranged in concentric layers in order to withstand arterial pressure. The number of medial elastin layers from the proximal thoracic aorta to the infrarenal aorta is markedly reduced, with medial thinning and intimal thickening. A reduction in collagen and elastin content is noted from the proximal to the distal aorta. Elastin is the principal load-bearing element in the aorta. Elastin fragmentation and degeneration are observed in aneurysm walls. The decrease in content coupled with the histological changes of this matrix protein in aneurysms may explain the propensity for aneurysm formation in the infrarenal aorta. Immunoreactive proteins are found more conspicuously in the abdominal aorta, and this may contribute to the increased frequency of aneurysms in this location. The aortic media appear to degrade in AAA by means of a proteolytic process. This implies an increase in the concentration of proteolytic enzymes relative to their inhibitors in the abdominal aorta as the individual ages. Reports have documented increased expression and activity of matrix metalloproteinases (MMPs) in persons with AAAs. MMPs and other proteases have been shown to be secreted into the extracellular matrix of AAAs by macrophages and aortic smooth muscle cells. MMPs and their inhibitors are present in normal aortic tissue and are responsible for vessel wall remodeling. In aneurysmal tissue, a tendency exists for increased MMP activity favoring the degradation of elastin and collagen. The mechanism that tips the balance in favor of degradation of elastin and collagen in the aortic wall of AAAs by MMPs and other proteases is presently unknown. AAAs demonstrate a chronic adventitial and medial inflammatory infiltrate upon histological examination. Infiltration of AAAs with lymphocytes and macrophages may trigger protease activation via various cytokines (interleukin [IL]–1, IL-6, IL-8, and tumor necrosis factor-alpha). Further study has defined a matrix protein that is immunoreactive with immunoglobulin G in the aneurysm wall. This autoantigen appears to be a collagen-associated microfibril. Certain infectious agents have been associated with the development of this protein, including Chlamydia pneumoniae and Treponema pallidum; however, a direct cause-and-effect relationship has not been demonstrated. AAAs arise as a result of a failure of the major structural proteins of the aorta (elastin and collagen). The inciting factors are not known, but a genetic predisposition clearly exists. Surgical specimens of AAA reveal inflammation, with infiltration by lymphocytes and macrophages; thinning of the media; and marked loss of elastin (see Image 4). Recent research has focused on the role of the metalloproteinases, a group of zinc-dependent enzymes responsible for tissue remodeling. In general, AAAs gradually enlarge (0.2-0.8 mm/y) and eventually rupture. Hemodynamics play an important role. Areas of high stress have been found in AAAs and appear to correlate with the site of rupture. Computer-generated geometric factors have demonstrated that aneurysm volume is a better predictor of areas of peak wall stress than aneurysm diameter. This may have implications in determining which AAAs require surgical repair. Additionally, molecular genetics has provided some insight into the development of AAAs. Through gene microarray analysis, various genes involved in extracellular matrix degradation, inflammation, and other processes observed in AAA formation have been shown to be up-regulated, while others that may serve to prevent this occurrence are down-regulated. The combination of proteolytic degradation of aortic wall connective tissue, inflammation and immune responses, biomechanical wall stress, and molecular genetics represents a dynamic process that leads to aneurysmal deterioration of aortic tissue. Clinical
Physical examination Bilateral upper extremity blood pressures are discernible in patients with AAAs. Hypertension may trigger a workup for renal artery stenosis. Unequal blood pressures (>30 mm Hg) indicate subclavian artery stenosis, and perioperative monitoring is important. Cervical bruits may indicate carotid artery stenosis. Abdominal examination includes palpation of the aorta and an estimation of the size of the aneurysm. Bruits may indicate the presence of renal or visceral artery stenosis; a thrill is possible with aortocaval fistulae. Regarding the peripheral pulses, palpate femoral popliteal and pedal pulses (dorsalis pedis or posterior tibial) to determine if an associated aneurysm (femoral/popliteal) or occlusive disease exists. Flank ecchymosis (Grey Turner sign) represents retroperitoneal hemorrhage. With respect to rectal aspects of the physical examination, guaiac-positive stool is present with associated colon cancer. Most persons with AAAs are asymptomatic. Patients may describe a pulse in the abdomen and may actually feel a pulsatile mass. At times, AAAs may cause symptoms from local compression, including early satiety, nausea, vomiting, urinary symptoms, or venous thrombosis from venous compression. Back pain can be caused by erosion of the AAA into adjacent vertebrae. Other symptoms include abdominal pain, groin pain, embolic phenomenon to the toes, and fever. Transient hypotension should prompt consideration of rupture because this finding can progress to frank shock over a period of hours. Temporary loss of consciousness is also a potential symptom of rupture. Most clinically significant aneurysms are palpable upon routine physical examination; however, the sensitivity of the technique is based on the experience of the examiner, the size of the aneurysm, and the size of the patient. In a recent study, 38% of AAA cases were detected based on physical examination findings, while 62% were detected incidentally based on radiologic studies obtained for other reasons. INDICATIONSSection 3 of 12
Even patients who do not have symptoms from their AAAs require surgical intervention because the result of medical management in this population is a mortality rate of 100% over time due to rupture. In addition, these patients have a high likelihood of limb loss from peripheral embolization. Monitor patients with AAAs smaller than 4 cm in diameter with ultrasound every 6 months, and offer surgical intervention if the aneurysm expands or causes symptoms. In patients with AAAs of 4-5 cm in diameter, elective repair may be of benefit if they are young, have a low operative risk, and have a good life expectancy. Additionally, AAAs in women have been shown to rupture at smaller diameters in comparison with men; therefore, a threshold of 4.5 cm for elective repair has been advocated in this patient population. Patients with AAAs of 5-6 cm in diameter may benefit from repair, especially if they have other contributing factors for rupture, including hypertension, continued smoking, or chronic obstructive pulmonary disease (COPD). For patients at higher risk, the threshold for repair may be a diameter of 6-7 cm, depending on their condition. At this size, the risk of rupture increases with age. These sizes apply to males of average height (170 cm). RELEVANT ANATOMYSection 4 of 12
The abdominal aorta maintains 3 distinct tissue layers, an intima, media, and adventitia. The intima is composed of the classic endothelial layer. The media contains vascular smooth muscle and matrix proteins, elastin, and collagen. The diameter of the aorta decreases in size from its thoracic portion to the abdominal and infrarenal portions. A normal aorta shows a reduction in medial elastin layers from the thoracic area to the abdominal portion. Elastin and collagen content are also reduced. Aneurysms represent a dilatation in all layers of the vessel wall. The shape of the aneurysm can be described as saccular or fusiform, although this description represents a continuum. Aneurysm diameter is an important risk factor for rupture. The important surgical and endovascular anatomic considerations include associated renal and visceral artery involvement (either occlusive disease or involved in the aneurysm process) and the iliac artery (either occlusive disease or aneurysms). The length of the infrarenal aortic neck is important in helping determine the surgical approach (retroperitoneal vs transabdominal) and the location of the aortic cross clamp. Hypogastric artery (internal iliac) outflow is important in planning surgical repair. Loss of blood flow from the hypogastric artery may result in impotence in males and sigmoid colon ischemia with necrosis. Inflammatory aneurysms represent a subsegment of AAA and are characterized by a thick inflammatory peal. These aneurysms are associated with retroperitoneal fibrosis and adhesion of the duodenum and fibrosis (see Image 7). CONTRAINDICATIONSSection 5 of 12
Contraindications for operative intervention include severe COPD, severe cardiac disease, active infection, and medical problems that preclude operative intervention. These patients may benefit best from endovascular stenting of the aneurysm. Severe life-threatening comorbidities include advanced cancer, end-stage lung disease, or cardiac disease. In many patients, the decision to operate is a balance between risks and benefits. In an elderly patient (>80 y) with significant comorbidities, surgical repair may not be indicated. The decision to intervene should not be based on age alone, even with rupture. The decision is best based on the patient's overall physical status, including a positive attitude toward the surgery. Patients with known cancer with an indolent course (ie, prostate cancer) may merit aneurysm repair if their estimated survival is 2 years or longer. WORKUPSection 6 of 12
Lab Studies
Imaging Studies
Other Tests
Histologic FindingsAAAs contain a chronic inflammatory infiltrate and neovascularity of varying degrees. Inflammatory AAAs may contain germinal centers. TREATMENTSection 7 of 12
Medical therapyIn patients with small AAAs, attempt to reduce the expansion rate and rupture risk. Smoking cessation is of paramount importance. Aggressively control hypertension. Institute beta-blocker therapy to reduce blood pressure and stress on the artery wall. These can be administered safely unless the patient has contraindications to their use, such as COPD, allergy to the drug, bradycardia, or severe CHF. Surgical therapyThe decision to treat an AAA is based on operative risk, the risk of rupture, and the patient’s estimated life expectancy. In 2003, the Society for Vascular Surgery (SVS) published a series of guidelines for the treatment of AAAs based on these principles.6 The operative risk is based on patients’ comorbidities and hospital factors. Patient characteristics, including age, gender, renal function, and cardiopulmonary disease are perhaps the most important (see Table 1).
Furthermore, lower volume hospitals and surgeons are associated with higher mortality.7 The risk of rupture is generally related to size (see Table 2), but other patient variables are important. Table 2. Estimated Annual Rupture Risk Preoperative detailsPreoperatively, obtain a careful history and perform a physical examination and laboratory assessment. From the information derived from these basic assessments, perioperative risk and life expectancy after the proposed procedure can be estimated. Carefully consider whether the patient's current quality of life is sufficient to justify the operative intervention. Because the disease process affects elderly persons who may be debilitated or may have mental deterioration, this decision is made in conjunction with the patient and family. Once the decision is made, identify comorbidities and risk factors that increase the operative risk or decrease survival. Ascertain the patient's activity level, stamina, and stability of health. Perform a thorough cardiac assessment tailored in accordance with the patient's history, symptomatology, and results from preliminary screening tests such as the electrocardiogram and stress test. Because COPD is an independent predictor of operative mortality, assess lung function by performing a room-air arterial blood gas measurement and pulmonary function tests. In patients with abnormal test results, preoperative intervention in the form of bronchodilators and pulmonary toilet often can reduce operative risks and postoperative complications. Preoperative intravenous antibiotics (usually a cephalosporin) are administered to reduce the risk of infection. Arranging for appropriate intravenous accesses to accommodate blood loss, arterial pressure monitoring through an arterial line, and Foley catheter placement to monitor urine output are routine preparations for surgery. For patients at high risk because of cardiac compromise, a Swan-Ganz catheter is placed to assist with cardiac monitoring and volume assessment. Transesophageal echocardiography can be useful to monitor ventricular volume and cardiac wall motion and to provide a guide with respect to fluid replacement and pressor use. Prepare for blood replacement. The patient should have blood available for transfusion. Intraoperative Cell Saver use and preoperative autologous blood donation have become popular. Maintain a normal body temperature during the operative intervention to prevent coagulopathy and maintain normal metabolic function. To prevent hypothermia, place a recirculating, warm forced-air blanket on the patient and warm any intravenous fluids and blood before administration. The following are standard preoperatively:
Intraoperative detailsApproach The aorta may be approached either transabdominally or through the retroperitoneal space. Approach juxtarenal and suprarenal aortic aneurysms from the left retroperitoneal space. Self-retaining retractors are used. Keep the bowel warm and, if possible, not exteriorized. The abdomen is explored for abnormalities (eg, gallstones, associated intestinal or pancreatic malignancy). Depending on the patient's anatomy, the aorta can be reconstructed with a tube graft, an aortic iliac bifurcation graft, or an aortofemoral bypass. For proximal infrarenal control, first identify the left renal vein. Occasionally, patients may have a retroaortic vein (<5%). In this situation, take care when placing the proximal clamp. Division of the left renal vein is usually required to clamp above the renal arteries. Regarding pelvic outflow, in most instances, the inferior mesenteric artery is sacrificed. Therefore, to prevent colon ischemia, make every attempt to restore at least one hypogastric (internal iliac) artery perfusion. If the hypogastric arteries are sacrificed (associated aneurysms), reimplant the inferior mesenteric artery. For supraceliac aortic control, first divide the ligaments to the left lateral segment of the liver and then retract the segment. The crura of the diaphragm are separated, and the aorta is bluntly dissected. Supraceliac control is recommended for inflammatory aneurysms. The aorta is reconstructed from within using PTFE or Dacron. The aneurysm sac is closed, and the graft is put into the duodenum to prevent erosion. Special considerations Inflammatory aneurysms require supraceliac control, minimal dissection of the duodenum, and balloon occlusion of the iliac arteries. In patients with inflammatory aneurysms or large iliac artery aneurysms, identify the ureters; occasionally, ureteral stents are recommended in patients with inflammatory aneurysms. Prevention of distal embolization The patient is heparinized (5000 U intravenously) prior to aortic cross-clamping. If significant intraluminal debris, juxtarenal thrombus, or prior peripheral embolization is present, the distal arteries are clamped first, followed by aortic clamping. Before restoring lower extremity blood flow, both forward flow (aortic) and back flow (iliac) are allowed to remove debris. The graft is also irrigated to flush out debris. The colon is inspected prior to closure, and the femoral arteries are palpated. Before the patient leaves the operating room, determine lower extremity circulation. If a clot was dislodged at the time of aortic clamping, it can be removed with a Fogarty embolectomy catheter. Heparin reversal is not usually required. Postoperative detailsFluid shifts are common following aortic surgery. Fluid requirements may be high in the first 12 hours, depending on the amount of blood loss and fluid resuscitation in the operating room. Monitor the patient in the surgical intensive care unit for hemodynamic stability, bleeding, urine output, and peripheral pulses. A postoperative electrocardiogram and chest radiograph are needed. Prophylactic antibiotics (eg, cefazolin at 1 g) are administered for 24 hours. Follow-upThe patient is seen in 1-2 weeks for suture or skin staple removal, then yearly thereafter. For excellent patient education resources, visit eMedicine's Circulatory Problems Center and Cholesterol Center. Also, see eMedicine's patient education articles Aortic Aneurysm, High Cholesterol, and Cholesterol FAQs. COMPLICATIONSSection 8 of 12
OUTCOME AND PROGNOSISSection 9 of 12
The long-term prognosis is related to associated comorbidities. Long-term survival is shortened by CHF and COPD. Rupture of associated thoracic aneurysms is also an important cause of late death. Overall, AAA repair is very durable with few long-term complications (<5% false aneurysm). In general, the survival rate of people with successful aortic aneurysm repair is comparable to that of people in the age-matched population at large who have never had an aneurysm. FUTURE AND CONTROVERSIESSection 10 of 12
Endovascular stent grafts for the treatment of AAA are a less invasive form of treatment. Patients are discharged 1-2 days following surgery. The graft is placed through 2 small incisions. In September 2000, 2 grafts were approved by the US Food and Drug Administration (FDA). Since then, several more devices have received FDA approval. Recently, the FDA has recommended careful follow-up because of persistent endoleaks and late ruptures. In some instances, endoleaks represent continued pressurization of the sac (see Image 9). Aneurysm sacs may also demonstrate elevated pressure despite the absence of a demonstrable endoleak. This has been described as "endotension." Persistently elevated aneurysm sac pressure, whether secondary to endoleak or endotension, is worrisome because it may progress to AAA rupture. Early data demonstrated a need for secondary interventions, via endovascular techniques, in as many as 10% of patients per year following endovascular aneurysm repair, compared with 2% in the first 5 years for open repair. Improvement has been made in the rate of secondary interventions following endovascular repair, but long-term durability has yet to be determined. Informing the patient about these potential problems is important prior to implanting these grafts. In addition, patients with endografts require follow-up evaluation with serial CT scanning on a schedule that demands more office visits than are required for patients who receive conventional grafts. Currently, endovascular repair is advocated by many physicians for patients at increased risk for open aneurysm repair, but until results from randomized controlled trials are available, patient preference is the strongest determinant in deciding between endovascular and open aneurysm repair. MULTIMEDIASection 11 of 12
REFERENCESSection 12 of 12
Abdominal Aortic Aneurysm excerpt Article Last Updated: Dec 17, 2007 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
